SEC Form 5 · accession 0001511164-17-000432
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock (Restricted) | Jan 2, 2015 | D | 1,100,000 | $0.05 | D | 26,457,183 | D | |
| INVO Bioscience Common Stock (Restricted) | Jan 16, 2015 | D | 50,000 | $0.10 | D | 26,407,183 | D | |
| INVO Bioscience Common Stock (Restricted) | Mar 17, 2015 | D | 125,000 | $0.20 | D | 26,282,183 | D | |
| INVO Bioscience Common Stock (Restricted) | Jun 29, 2015 | D | 120,000 | $0.25 | D | 26,162,183 | D | |
| INVO Bioscience Common Stock (Restricted) | Jun 29, 2015 | D | 3,750 | $0.40 | D | 26,158,433 | D | |
| INVO Bioscience Common Stock (Restricted) | Jun 29, 2015 | D | 2,500 | $0.40 | D | 26,155,933 | D |
Table II — derivative securities
Remarks
On 01/02/2015 and 01/16/2015, the same private investors who already had a loan/debt in 2013 and 2014 equivalent to 1,600,000 shares successively reinvested $55,000 equivalent to 50,000 restricted shares. The total of the loans from 2013 and 2014 and 2015 were equivalent to 1,600,000 (2013 + 2014) + 1,15,0000 (2015) = 2,750,000 restricted shares. On 02/02/2015, these shares were issued in the stock certificate #1565. On 03/17/2015 and 06/29/2015, 4 more stock certificates were issued, #1574, 1586, 1585, 1584 to 4 different investors with respectively 125,000, 120,000, 3,750 and 2500 shares, totaling 251,250 restricted shares. On 12/31/2015, I owned 27,557,183 (2014) - 1,150,000 - 251,250 = 26,155,933 shares.